Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Mauna Kea Technologies Receives FDA Clearance And CE Marking For Its Next-Generation Cellvizio® Platform
Mauna Kea Technologies Receives FDA Clearance And CE Marking For Its Next-Generation Cellvizio® Platform


Regulatory News:



Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE)

BusinessWire_EN 
0 03.03.20
GenSight Biologics Announces Presentation of Bilateral Visual Recovery From GS010 (LUMEVOQ™) Phase III Trials at the 46th Annual Meeting of NANOS
GenSight Biologics Announces Presentation of Bilateral Visual Recovery From GS010 (LUMEVOQ™) Phase III Trials at the 46th Annual Meeting of NANOS


Regulatory News:



GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for

BusinessWire_EN 
0 03.03.20
EOS imaging: Information Relating to the Total Number of Share Capital and Voting Rights
EOS imaging: Information Relating to the Total Number of Share Capital and Voting Rights


Regulatory News:



EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

BusinessWire_EN 
0 27.01.20
Mauna Kea Technologies Receives FDA 510(k) Clearance of Cellvizio® with a Fluorescent Dye, Fluorescein, as Drug Device Combination
Mauna Kea Technologies Receives FDA 510(k) Clearance of Cellvizio® with a Fluorescent Dye, Fluorescein, as Drug Device Combination


Regulatory News:



Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (pCLE/nCLE)

BusinessWire_EN 
0 27.01.20
EOS imaging Announces First Installation of EOSedge™ in North America
EOS imaging Announces First Installation of EOSedge™ in North America


Regulatory News:



EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

BusinessWire_EN 
0 21.01.20
EOS imaging Reports Its Full Year 2019 Sales
EOS imaging Reports Its Full Year 2019 Sales


Regulatory News:



EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

BusinessWire_EN 
0 15.01.20
Mauna Kea Technologies Announces Publication of Positive Results on Needle-Based Endomicroscopy for the Clinical Management of Pancreatic Cystic Lesions
Mauna Kea Technologies Announces Publication of Positive Results on Needle-Based Endomicroscopy for the Clinical Management of Pancreatic Cystic Lesions


Regulatory News:



Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today

BusinessWire_EN 
0 08.01.20
EOS imaging Announces Its Financial Agenda For 2020
EOS imaging Announces Its Financial Agenda For 2020


Regulatory News:



EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

BusinessWire_EN 
0 19.12.19
Mauna Kea Technologies Announces Strategic Equity Investment of €7.5 Million by Johnson & Johnson Innovation
Mauna Kea Technologies Announces Strategic Equity Investment of €7.5 Million by Johnson & Johnson Innovation


Regulatory News:



Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE)

BusinessWire_EN 
0 16.12.19
GenSight Biologics reports findings from REALITY study and REVERSE-RESCUE analysis highlighting positive benefits from LUMEVOQ™ (GS010) compared to LHON natural history
GenSight Biologics reports findings from REALITY study and REVERSE-RESCUE analysis highlighting positive benefits from LUMEVOQ™ (GS010) compared to LHON natural history


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191210006078/en/



Figure 1. LHON Natural History from Interim Analysis


BusinessWire_EN 
0 11.12.19
The Quinze-Vingts Hospital and GenSight Biologics Announce a First Temporary Authorization for Use (ATU) for LUMEVOQ™ (GS010) in France
The Quinze-Vingts Hospital and GenSight Biologics Announce a First Temporary Authorization for Use (ATU) for LUMEVOQ™ (GS010) in France


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191208005050/en/



The National Eye Hospital (CHNO) of the Quinze-Vingt

BusinessWire_EN 
0 09.12.19
EOS imaging RECEIVES U.S. FDA 510(K) CLEARANCE FOR EOSedge™ ITS NEW GENERATION INNOVATIVE IMAGING SYSTEM
EOS imaging RECEIVES U.S. FDA 510(K) CLEARANCE FOR EOSedge™ ITS NEW GENERATION INNOVATIVE IMAGING SYSTEM


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191128005574/en/



EOSedge™ (Photo: Business Wire)




EOS imaging

BusinessWire_EN 
0 29.11.19
EOS imaging Announces the Upcoming Launch of EOSedge™, Its New Generation Imaging System
EOS imaging Announces the Upcoming Launch of EOSedge™, Its New Generation Imaging System


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191126005639/en/



(Photo: Business Wire)




EOS imaging (Paris:EOSI)

BusinessWire_EN 
0 26.11.19
EOS imaging Announces 350th System Worldwide Installed at University of Missouri Health Care
EOS imaging Announces 350th System Worldwide Installed at University of Missouri Health Care


Regulatory News:



EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

BusinessWire_EN 
0 12.11.19
EOS imaging to Present Advanced Orthopedic Solutions at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting 2019
EOS imaging to Present Advanced Orthopedic Solutions at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting 2019


Regulatory News:



EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

BusinessWire_EN 
0 08.11.19
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE AU 28/02/2018
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE AU 28/02/2018
INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....
Actusnews 
0 15.03.18
ALPHA MOS : CHIFFRE D'AFFAIRES ANNUEL 2017
ALPHA MOS : CHIFFRE D'AFFAIRES ANNUEL 2017
En M€ - Normes IFRS Données consolidées non auditées 2017 2016 Variation Chiffre d'affaires 4,0 7,5  -46% Alpha MOS (Euronext Paris – Compartiment C – Code ISIN :....
Actusnews 
0 16.02.18
ALPHA MOS : DEMISSION D'OLIVIER SICHEL DE SON POSTE D'ADMINISTRATEUR ALPHA MOS
ALPHA MOS : DEMISSION D'OLIVIER SICHEL DE SON POSTE D'ADMINISTRATEUR ALPHA MOS
Monsieur Olivier SICHEL, administrateur indépendant au sein du Conseil d'administration d'Alpha MOS, a informé le Conseil de sa décision de mettre un terme à ses fonctions avec effet au 19....
Actusnews 
0 29.12.17
ALPHA MOS : Informations relatives au nombre total de droits de vote
ALPHA MOS : Informations relatives au nombre total de droits de vote
INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....
Actusnews 
0 06.12.17
ALPHA MOS : CHIFFRE D'AFFAIRES NEUF MOIS 2017
ALPHA MOS : CHIFFRE D'AFFAIRES NEUF MOIS 2017
En M€ - Normes IFRS Données non auditées 2017 2016 Variation Chiffre d'affaires 1er semestre 2,1 3,9  -47% Chiffre d'affaires 3ème....
Actusnews 
0 27.10.17
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS
INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....
Actusnews 
0 13.10.17
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE
ALPHA MOS : INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE
 INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS PREVUES PAR L'ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L'ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AUTORITE DES MARCHES....
Actusnews 
0 26.09.17
ALPHA MOS : COMMUNIQUE DE MISE A DISPOSITION DE LA NOTE EN REPONSE
ALPHA MOS : COMMUNIQUE DE MISE A DISPOSITION DE LA NOTE EN REPONSE
OFFRE PUBLIQUE D'ACHAT SIMPLIFIEE VISANT LES ACTIONS DE LA SOCIETE ALPHA MOS INITIEE CONJOINTEMENT PAR JOLT CAPITAL AMBROSIA INVESTMENTS PRESENTEE PAR ALANTRA COMMUNIQUE DE MISE....
Actusnews 
0 20.09.17
ALPHA MOS : RESULTATS SEMESTRIELS 2017
ALPHA MOS : RESULTATS SEMESTRIELS 2017
Au cours de sa réunion du 11 septembre 2017, le Conseil d'administration d'Alpha MOS (Euronext Paris - Compartiment C - Code ISIN : FR0000062804-ALM) a arrêté les comptes semestriels 2017,....
Actusnews 
0 13.09.17
ALPHA MOS : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2017
ALPHA MOS : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2017
Alpha MOS (Euronext Paris - Compartiment C - Code ISIN : FR0000062804-ALM) annonce, ce jour, avoir mis à la disposition du public et déposé auprès de l'Autorité des marchés financiers (AMF)....
Actusnews 
0 13.09.17